Selected research
Industry Research
Mice Model Genetic Engineering Industry Research Report 2026
Market perspective
The global Mice Model Genetic Engineering market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Mice Model Genetic Engineering market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Mice Model Genetic Engineering market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Mice Model Genetic Engineering market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Mice Model Genetic Engineering include B BIOCYTOGEN, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Ozgene Pty Ltd., Taconic Biosciences, Inc. and PolyGene AG, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Mice Model Genetic Engineering market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Mice Model Genetic Engineering.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mice Model Genetic Engineering Market by Company
B BIOCYTOGEN
Charles River Laboratories
Cyagen Biosciences
Gempharmatech
genOway
ingenious targeting laboratory
Ozgene Pty Ltd.
Taconic Biosciences, Inc.
PolyGene AG
THE JACKSON LABORATORY
Yale School of Medicine
University of North Carolina
University of Nebraska Medical Center
Monash University
UMass Chan Medical School
University of Bonn
Columbia University
The University of Arizona
The Weizmann Institute of Science
The Hebrew University of Jerusalem
The Technion – Israel Institute of Technology
Hadassah BrainLabs
Mice Model Genetic Engineering Segment by Type
CRISPR Knockout
CRISPR Knockin
Random Insertions
ES Cell Modification (homologous recombination)
Others
Mice Model Genetic Engineering Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic & Research Facilities
Contract Research & Manufacturing Organizations
Mice Model Genetic Engineering Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mice Model Genetic Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mice Model Genetic Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mice Model Genetic Engineering.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Mice Model Genetic Engineering companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- CRISPR Knockout
- CRISPR Knockin
- Random Insertions
- ES Cell Modification (homologous recombination)
- Others
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Facilities
- Contract Research & Manufacturing Organizations
Companies covered
- B BIOCYTOGEN
- Charles River Laboratories
- Cyagen Biosciences
- Gempharmatech
- genOway
- ingenious targeting laboratory
- Ozgene Pty Ltd.
- Taconic Biosciences, Inc.
- PolyGene AG
- THE JACKSON LABORATORY
- Yale School of Medicine
- University of North Carolina
- University of Nebraska Medical Center
- Monash University
- UMass Chan Medical School
- University of Bonn
- Columbia University
- The University of Arizona
- The Weizmann Institute of Science
- The Hebrew University of Jerusalem
- The Technion – Israel Institute of Technology
- Hadassah BrainLabs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Mice Model Genetic Engineering by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 CRISPR Knockout
- 2.2.3 CRISPR Knockin
- 2.2.4 Random Insertions
- 2.2.5 ES Cell Modification (homologous recombination)
- 2.2.6 Others
- 2.3 Mice Model Genetic Engineering by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Biotechnology Companies
- 2.3.4 Academic & Research Facilities
- 2.3.5 Contract Research & Manufacturing Organizations
- 2.4 Assumptions and Limitations
3 Mice Model Genetic Engineering Breakdown Data by Type
- 3.1 Global Mice Model Genetic Engineering Historic Market Size by Type (2021-2026)
- 3.2 Global Mice Model Genetic Engineering Forecasted Market Size by Type (2027-2032)
4 Mice Model Genetic Engineering Breakdown Data by Application
- 4.1 Global Mice Model Genetic Engineering Historic Market Size by Application (2021-2026)
- 4.2 Global Mice Model Genetic Engineering Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Mice Model Genetic Engineering Market Perspective (2021-2032)
- 5.2 Global Mice Model Genetic Engineering Growth Trends by Region
- 5.2.1 Global Mice Model Genetic Engineering Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Mice Model Genetic Engineering Historic Market Size by Region (2021-2026)
- 5.2.3 Mice Model Genetic Engineering Forecasted Market Size by Region (2027-2032)
- 5.3 Mice Model Genetic Engineering Market Dynamics
- 5.3.1 Mice Model Genetic Engineering Industry Trends
- 5.3.2 Mice Model Genetic Engineering Market Drivers
- 5.3.3 Mice Model Genetic Engineering Market Challenges
- 5.3.4 Mice Model Genetic Engineering Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Mice Model Genetic Engineering Players by Revenue
- 6.1.1 Global Top Mice Model Genetic Engineering Players by Revenue (2021-2026)
- 6.1.2 Global Mice Model Genetic Engineering Revenue Market Share by Players (2021-2026)
- 6.2 Global Mice Model Genetic Engineering Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Mice Model Genetic Engineering Head Office and Area Served
- 6.4 Global Mice Model Genetic Engineering Players, Product Type & Application
- 6.5 Global Mice Model Genetic Engineering Manufacturers Established Date
- 6.6 Global Mice Model Genetic Engineering Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Mice Model Genetic Engineering Market Size (2021-2032)
- 7.2 North America Mice Model Genetic Engineering Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 7.4 North America Mice Model Genetic Engineering Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Mice Model Genetic Engineering Market Size (2021-2032)
- 8.2 Europe Mice Model Genetic Engineering Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 8.4 Europe Mice Model Genetic Engineering Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Mice Model Genetic Engineering Market Size (2021-2032)
- 9.2 Asia-Pacific Mice Model Genetic Engineering Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Mice Model Genetic Engineering Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Mice Model Genetic Engineering Market Size (2021-2032)
- 10.2 South America Mice Model Genetic Engineering Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 10.4 South America Mice Model Genetic Engineering Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Mice Model Genetic Engineering Market Size (2021-2032)
- 11.2 Middle East & Africa Mice Model Genetic Engineering Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 B BIOCYTOGEN
- 12.1.1 B BIOCYTOGEN Company Information
- 12.1.2 B BIOCYTOGEN Business Overview
- 12.1.3 B BIOCYTOGEN Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.1.4 B BIOCYTOGEN Mice Model Genetic Engineering Product Portfolio
- 12.1.5 B BIOCYTOGEN Recent Developments
- 12.2 Charles River Laboratories
- 12.2.1 Charles River Laboratories Company Information
- 12.2.2 Charles River Laboratories Business Overview
- 12.2.3 Charles River Laboratories Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.2.4 Charles River Laboratories Mice Model Genetic Engineering Product Portfolio
- 12.2.5 Charles River Laboratories Recent Developments
- 12.3 Cyagen Biosciences
- 12.3.1 Cyagen Biosciences Company Information
- 12.3.2 Cyagen Biosciences Business Overview
- 12.3.3 Cyagen Biosciences Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.3.4 Cyagen Biosciences Mice Model Genetic Engineering Product Portfolio
- 12.3.5 Cyagen Biosciences Recent Developments
- 12.4 Gempharmatech
- 12.4.1 Gempharmatech Company Information
- 12.4.2 Gempharmatech Business Overview
- 12.4.3 Gempharmatech Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.4.4 Gempharmatech Mice Model Genetic Engineering Product Portfolio
- 12.4.5 Gempharmatech Recent Developments
- 12.5 genOway
- 12.5.1 genOway Company Information
- 12.5.2 genOway Business Overview
- 12.5.3 genOway Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.5.4 genOway Mice Model Genetic Engineering Product Portfolio
- 12.5.5 genOway Recent Developments
- 12.6 ingenious targeting laboratory
- 12.6.1 ingenious targeting laboratory Company Information
- 12.6.2 ingenious targeting laboratory Business Overview
- 12.6.3 ingenious targeting laboratory Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.6.4 ingenious targeting laboratory Mice Model Genetic Engineering Product Portfolio
- 12.6.5 ingenious targeting laboratory Recent Developments
- 12.7 Ozgene Pty Ltd.
- 12.7.1 Ozgene Pty Ltd. Company Information
- 12.7.2 Ozgene Pty Ltd. Business Overview
- 12.7.3 Ozgene Pty Ltd. Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.7.4 Ozgene Pty Ltd. Mice Model Genetic Engineering Product Portfolio
- 12.7.5 Ozgene Pty Ltd. Recent Developments
- 12.8 Taconic Biosciences, Inc.
- 12.8.1 Taconic Biosciences, Inc. Company Information
- 12.8.2 Taconic Biosciences, Inc. Business Overview
- 12.8.3 Taconic Biosciences, Inc. Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.8.4 Taconic Biosciences, Inc. Mice Model Genetic Engineering Product Portfolio
- 12.8.5 Taconic Biosciences, Inc. Recent Developments
- 12.9 PolyGene AG
- 12.9.1 PolyGene AG Company Information
- 12.9.2 PolyGene AG Business Overview
- 12.9.3 PolyGene AG Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.9.4 PolyGene AG Mice Model Genetic Engineering Product Portfolio
- 12.9.5 PolyGene AG Recent Developments
- 12.10 THE JACKSON LABORATORY
- 12.10.1 THE JACKSON LABORATORY Company Information
- 12.10.2 THE JACKSON LABORATORY Business Overview
- 12.10.3 THE JACKSON LABORATORY Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.10.4 THE JACKSON LABORATORY Mice Model Genetic Engineering Product Portfolio
- 12.10.5 THE JACKSON LABORATORY Recent Developments
- 12.11 Yale School of Medicine
- 12.11.1 Yale School of Medicine Company Information
- 12.11.2 Yale School of Medicine Business Overview
- 12.11.3 Yale School of Medicine Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.11.4 Yale School of Medicine Mice Model Genetic Engineering Product Portfolio
- 12.11.5 Yale School of Medicine Recent Developments
- 12.12 University of North Carolina
- 12.12.1 University of North Carolina Company Information
- 12.12.2 University of North Carolina Business Overview
- 12.12.3 University of North Carolina Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.12.4 University of North Carolina Mice Model Genetic Engineering Product Portfolio
- 12.12.5 University of North Carolina Recent Developments
- 12.13 University of Nebraska Medical Center
- 12.13.1 University of Nebraska Medical Center Company Information
- 12.13.2 University of Nebraska Medical Center Business Overview
- 12.13.3 University of Nebraska Medical Center Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.13.4 University of Nebraska Medical Center Mice Model Genetic Engineering Product Portfolio
- 12.13.5 University of Nebraska Medical Center Recent Developments
- 12.14 Monash University
- 12.14.1 Monash University Company Information
- 12.14.2 Monash University Business Overview
- 12.14.3 Monash University Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.14.4 Monash University Mice Model Genetic Engineering Product Portfolio
- 12.14.5 Monash University Recent Developments
- 12.15 UMass Chan Medical School
- 12.15.1 UMass Chan Medical School Company Information
- 12.15.2 UMass Chan Medical School Business Overview
- 12.15.3 UMass Chan Medical School Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.15.4 UMass Chan Medical School Mice Model Genetic Engineering Product Portfolio
- 12.15.5 UMass Chan Medical School Recent Developments
- 12.16 University of Bonn
- 12.16.1 University of Bonn Company Information
- 12.16.2 University of Bonn Business Overview
- 12.16.3 University of Bonn Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.16.4 University of Bonn Mice Model Genetic Engineering Product Portfolio
- 12.16.5 University of Bonn Recent Developments
- 12.17 Columbia University
- 12.17.1 Columbia University Company Information
- 12.17.2 Columbia University Business Overview
- 12.17.3 Columbia University Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.17.4 Columbia University Mice Model Genetic Engineering Product Portfolio
- 12.17.5 Columbia University Recent Developments
- 12.18 The University of Arizona
- 12.18.1 The University of Arizona Company Information
- 12.18.2 The University of Arizona Business Overview
- 12.18.3 The University of Arizona Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.18.4 The University of Arizona Mice Model Genetic Engineering Product Portfolio
- 12.18.5 The University of Arizona Recent Developments
- 12.19 The Weizmann Institute of Science
- 12.19.1 The Weizmann Institute of Science Company Information
- 12.19.2 The Weizmann Institute of Science Business Overview
- 12.19.3 The Weizmann Institute of Science Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.19.4 The Weizmann Institute of Science Mice Model Genetic Engineering Product Portfolio
- 12.19.5 The Weizmann Institute of Science Recent Developments
- 12.20 The Hebrew University of Jerusalem
- 12.20.1 The Hebrew University of Jerusalem Company Information
- 12.20.2 The Hebrew University of Jerusalem Business Overview
- 12.20.3 The Hebrew University of Jerusalem Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.20.4 The Hebrew University of Jerusalem Mice Model Genetic Engineering Product Portfolio
- 12.20.5 The Hebrew University of Jerusalem Recent Developments
- 12.21 The Technion – Israel Institute of Technology
- 12.21.1 The Technion – Israel Institute of Technology Company Information
- 12.21.2 The Technion – Israel Institute of Technology Business Overview
- 12.21.3 The Technion – Israel Institute of Technology Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.21.4 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Product Portfolio
- 12.21.5 The Technion – Israel Institute of Technology Recent Developments
- 12.22 Hadassah BrainLabs
- 12.22.1 Hadassah BrainLabs Company Information
- 12.22.2 Hadassah BrainLabs Business Overview
- 12.22.3 Hadassah BrainLabs Revenue in Mice Model Genetic Engineering Business (2021-2026)
- 12.22.4 Hadassah BrainLabs Mice Model Genetic Engineering Product Portfolio
- 12.22.5 Hadassah BrainLabs Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst